Immuneering Corp. (IMRX)
3.495
+0.04
(+1.01%)
USD |
NASDAQ |
Nov 18, 16:00
3.495
0.00 (0.00%)
After-Hours: 19:20
Immuneering Price to Book Value : 1.342 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.328 |
| November 16, 2026 | 1.352 |
| November 13, 2026 | 1.424 |
| November 12, 2026 | 1.409 |
| November 11, 2026 | 1.455 |
| November 10, 2026 | 1.478 |
| November 09, 2026 | 1.401 |
| November 06, 2026 | 1.413 |
| November 05, 2026 | 1.294 |
| November 04, 2026 | 1.444 |
| November 03, 2026 | 1.413 |
| November 02, 2026 | 1.340 |
| October 30, 2026 | 1.438 |
| October 29, 2026 | 1.543 |
| October 28, 2026 | 1.532 |
| October 27, 2026 | 1.470 |
| October 26, 2026 | 1.424 |
| October 23, 2026 | 1.432 |
| October 22, 2026 | 1.463 |
| October 21, 2026 | 1.436 |
| October 20, 2026 | 1.432 |
| October 19, 2026 | 1.405 |
| October 16, 2026 | 1.378 |
| October 15, 2026 | 1.398 |
| October 14, 2026 | 1.313 |
| Date | Value |
|---|---|
| October 13, 2026 | 1.367 |
| October 12, 2026 | 1.482 |
| October 09, 2026 | 1.513 |
| October 08, 2026 | 1.436 |
| October 07, 2026 | 1.482 |
| October 06, 2026 | 1.470 |
| October 05, 2026 | 1.551 |
| October 02, 2026 | 1.563 |
| October 01, 2026 | 1.547 |
| September 30, 2026 | 1.572 |
| September 29, 2026 | 1.401 |
| September 28, 2026 | 1.411 |
| September 25, 2026 | 1.448 |
| September 24, 2026 | 1.472 |
| September 23, 2026 | 1.486 |
| September 22, 2026 | 1.564 |
| September 21, 2026 | 1.506 |
| September 18, 2026 | 1.520 |
| September 17, 2026 | 1.513 |
| September 16, 2026 | 1.509 |
| September 15, 2026 | 1.506 |
| September 14, 2026 | 1.469 |
| September 11, 2026 | 1.448 |
| September 10, 2026 | 1.550 |
| September 09, 2026 | 1.564 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.221 |
| Alnylam Pharmaceuticals, Inc. | 5.553 |
| Anika Therapeutics, Inc. | 1.326 |
| Savara, Inc. | 9.024 |
| Arrowhead Pharmaceuticals, Inc. | 121.09 |
Price to Book Value Related Metrics
| Price | 3.495 |
| Earnings Yield | -29.42% |
| Market Cap | 226.35M |